Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl]-L-tryptophan methylamide. - Galardy,R.E.; Grobelny,D.; Foellmer,H.G.; Fernadez,L.A. (Cancer Res, 1994)